CoChat

Identifying high-risk population of depression: association between metabolic syndrome and depression using a health checkup and claims database

Open access
Imaizumi, Takahiro, Toda, Takuya, Maekawa, Michitaka, Sakurai, Daisuke, Hagiwara, Yuta, Yoshida, Yasuko, Ando, Masahiko, Maruyama, Shoichi · 2022 · Scientific Reports

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Depression and metabolic syndrome (MetS) are correlated, leading to an increased healthcare burden and decreased productivity. We aimed to investigate the association between MetS-related factors and depression using a health checkup and claims database. Individuals aged 18–75 years who underwent health examinations between 2014 and 2019 were enrolled in the study. Among 76,277 participants, “ever” and “incident” antidepressant users exhibited worse metabolic profiles and were more likely to be prescribed hypnotics and anxiolytics than “never” users. In a nested case–control study with a 1:10 ratio of incident users to controls, MetS was associated with incident antidepressant use (odds ratio, 1.53 [95% confidence interval 1.24–1.88]) adjusted for lifestyle information obtained from a self-administered questionnaire, medical history, and medications. Other metabolic traits also showed significant associations: body mass index (1.04 [1.02–1.06]), abdominal circumference per 10 cm (1.17 [1.08–1.27]), high blood pressure (1.17 [1.00–1.37]), glucose intolerance (1.29 [1.05–1.58]), and dyslipidemia (1.27 [1.08–1.51]). A bodyweight increase > 10 kg from age 20 years (1.46 [1.25–1.70]) was also significantly associated with incident antidepressant use. In conclusion, metabolic abnormalities were associated with incident antidepressant use and can be useful in identifying populations at high risk of depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-022-22048-9

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow diagram of study subject selection. Flow diagram of study subject selection. The descriptive cohort includes both ever and never users of antidepressants (N = 76,277). The nested case–control study was conducted at a 1:10 ratio of incidence density sampling from never users of antidepressants (N = 10,915).
Figure 1 Flow diagram of study subject selection. Flow diagram of study subject selection. The descriptive cohort includes both ever and never users of antidepressants (N = 76,277). The nested case–control study was conducted at a 1:10 ratio of incidence density sampling from never users of antidepressants (N = 10,915).CC BY · PubMed Central
Figure 2 Medication and hospitalization of never, ever, and incident users of antidepressants. Medication and hospitalization of never, ever, and incident users of antidepressants. NSAIDs non-steroidal anti-inflammatory drugs, CVD cardiovascular disease, HF heart failure.
Figure 2 Medication and hospitalization of never, ever, and incident users of antidepressants. Medication and hospitalization of never, ever, and incident users of antidepressants. NSAIDs non-steroidal anti-inflammatory drugs, CVD cardiovascular disease, HF heart failure.CC BY · PubMed Central
Figure 3 Design diagram of the study. A baseline health check was performed after April 2016. Each case had a lookback period of at least 2 years to assess laboratory data, medication, comorbidity, and hospitalization. Incidence density sampling was performed to conduct a nested case–control study.
Figure 3 Design diagram of the study. A baseline health check was performed after April 2016. Each case had a lookback period of at least 2 years to assess laboratory data, medication, comorbidity, and hospitalization. Incidence density sampling was performed to conduct a nested case–control study.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 2

  1. Langholz, B. & Goldstein, L. Risk set sampling in epidemiologic cohort studies. Stat. Sci. 11, 35–53 (1996).
  2. Allan, C. E., Valkanova, V. & Ebmeier, K. P. Depression in older people is underdiagnosed. Practitioner 258, 19–22 (2014).

Cited by

See all 15

Metadata

Authors
Imaizumi, T., Toda, T., Maekawa, M., Sakurai, D., Hagiwara, Y., Yoshida, Y., Ando, M., & Maruyama, S.
Affiliations
  • Nagoya University Hospital (JP)
  • Nagoya University (JP)
Corresponding author
  • Imaizumi, Takahiro
  • Maruyama, Shoichi
Venue
Scientific Reports
Published
2022-11-03
Volume
12
Issue
1
Pages
18577-18577
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4308497553
Cited by
12
References
49
Citations by year
2026: 1 · 2025: 6 · 2024: 3 · 2023: 2
FWCI
2.04
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
depression, metabolic syndrome, antidepressant use, incident depression, health checkups, claims database, body mass index, abdominal circumference, hypertension, impaired glucose tolerance, dyslipidemia, weight gain, high-risk population identification
MeSH terms
Depression, Humans, Risk Factors, Body Mass Index, Case-Control Studies, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identifying high-risk population of depression: association between metabolic syndrome and depression using a health checkup and claims database. https://app.cochat.ai/papers/10.1038/s41598-022-22048-9
The paper
Imaizumi, T., Toda, T., Maekawa, M., Sakurai, D., Hagiwara, Y., Yoshida, Y., Ando, M., & Maruyama, S. (2022). Identifying high-risk population of depression: association between metabolic syndrome and depression using a health checkup and claims database. Scientific Reports. https://doi.org/10.1038/s41598-022-22048-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.